175 related articles for article (PubMed ID: 35630545)
1. Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics.
Yang C; Alam A; Alhumaydhi FA; Khan MS; Alsagaby SA; Al Abdulmonem W; Hassan MI; Shamsi A; Bano B; Yadav DK
Molecules; 2022 May; 27(10):. PubMed ID: 35630545
[TBL] [Abstract][Full Text] [Related]
2. Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics.
Anjum F; Sulaimani MN; Shafie A; Mohammad T; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Alsagaby SA; Yadav DK; Hassan MI
RSC Adv; 2022 Mar; 12(13):7872-7882. PubMed ID: 35424745
[TBL] [Abstract][Full Text] [Related]
3. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy.
Hassan MI; Anjum D; Mohammad T; Alam M; Khan MS; Shahwan M; Shamsi A; Yadav DK
J Biomol Struct Dyn; 2023 Dec; 41(20):10558-10568. PubMed ID: 36495308
[TBL] [Abstract][Full Text] [Related]
4. Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations.
Shafie A; Khan S; Zehra ; Mohammad T; Anjum F; Hasan GM; Yadav DK; Hassan MI
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959438
[TBL] [Abstract][Full Text] [Related]
5. Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development.
Khan A; Bealy MA; Alharbi B; Khan S; Alharethi SH; Al-Soud WA; Mohammad T; Hassan MI; Alshammari N; Ahmed Al-Keridis L
J Biomol Struct Dyn; 2024; 42(4):1846-1857. PubMed ID: 37104027
[TBL] [Abstract][Full Text] [Related]
6. A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9.
Atiya A; Shahidi H; Mohammad T; Sharaf SE; Abdulmonem WA; Ashraf GM; Elasbali AM; Alharethi SH; Alhumaydhi FA; Baeesa SS; Rehan M; Shamsi A; Shahwan M
J Biomol Struct Dyn; 2023 Nov; 41(19):10202-10213. PubMed ID: 36562191
[TBL] [Abstract][Full Text] [Related]
7. An integrated docking and molecular dynamics simulation approach to discover potential inhibitors of activin receptor-like kinase 1.
Jairajpuri DS; Mohammad T; Hussain A; Amir S; Fatima U; AlAjmi MF; Yadav DK; Hassan MI
J Mol Recognit; 2024 Mar; 37(2):e3069. PubMed ID: 38053481
[TBL] [Abstract][Full Text] [Related]
8. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.
Adnan M; Shamsi A; Elasbali AM; Siddiqui AJ; Patel M; Alshammari N; Alharethi SH; Alhassan HH; Bardakci F; Hassan MI
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361954
[TBL] [Abstract][Full Text] [Related]
9. Desmodin and isopongachromene as potential inhibitors of cyclin-dependent kinase 5: phytoconstituents targeting anticancer and neurological therapy.
Atiya A; Batra S; Mohammad T; Alorfi NM; Abdulmonem WA; Alhumaydhi FA; Ashraf GM; Baeesa SS; Elasbali AM; Shahwan M
J Biomol Struct Dyn; 2023; 41(16):8042-8052. PubMed ID: 36184739
[TBL] [Abstract][Full Text] [Related]
10. Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach.
Alotaibi BS; Joshi J; Hasan MR; Khan MS; Alharethi SH; Mohammad T; Alhumaydhi FA; Elasbali AM; Hassan MI
J Biomol Struct Dyn; 2023; 41(14):6749-6758. PubMed ID: 35965440
[TBL] [Abstract][Full Text] [Related]
11. Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase.
Anjum F; Mohammad T; Almalki AA; Akhtar O; Abdullaev B; Hassan MI
OMICS; 2021 Sep; 25(9):580-590. PubMed ID: 34448628
[TBL] [Abstract][Full Text] [Related]
12. Identifying bioactive phytoconstituents as C-terminal Src kinase inhibitors: a virtual screening and molecular simulation approach.
Elfaki EM; Alhassan HH; Kamal M; Al-Enazi MM; Rub MA; Asiri AM; Ali M; Marwani HM; Alharethi SH; Alotaibi MM; Azum N
J Biomol Struct Dyn; 2023; 41(22):13415-13424. PubMed ID: 36752377
[TBL] [Abstract][Full Text] [Related]
13. Discovering Gummadiol and Isoarboreol as potential inhibitors of sphingosine kinase 1: virtual screening and MD simulation studies.
Elasbali AM; Al-Soud WA; Alhassan HH; Mousa Elayyan AE; Kamal M; Alanazi H; Alharbi B; Alharethi SH; Mohamed BM
J Biomol Struct Dyn; 2023; 41(22):12789-12797. PubMed ID: 36644886
[TBL] [Abstract][Full Text] [Related]
14. Identification of 11-Hydroxytephrosin and Torosaflavone A as Potential Inhibitors of 3-Phosphoinositide-Dependent Protein Kinase 1 (PDPK1): Toward Anticancer Drug Discovery.
Atiya A; Alhumaydhi FA; Sharaf SE; Al Abdulmonem W; Elasbali AM; Al Enazi MM; Shamsi A; Jawaid T; Alghamdi BS; Hashem AM; Ashraf GM; Shahwan M
Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009858
[TBL] [Abstract][Full Text] [Related]
15. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.
Alharbi B; Alnajjar LI; Alhassan HH; Khan S; Jawaid T; Abdullaev BS; Alshammari N; Yadav DK; Adnan M; Shamsi A
J Mol Recognit; 2024 Jan; 37(1):e3067. PubMed ID: 37956676
[TBL] [Abstract][Full Text] [Related]
16. Death-Associated Protein Kinase 3 Inhibitors Identified by Virtual Screening for Drug Discovery in Cancer and Hypertension.
Xue B; Chaddha M; Elasbali AM; Zhu Z; Jairajpuri DS; Alhumaydhi FA; Mohammad T; Abdulmonem WA; Sharaf SE; Hassan MI
OMICS; 2022 Jul; 26(7):404-413. PubMed ID: 35759452
[TBL] [Abstract][Full Text] [Related]
17. Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies.
Mohammad T; Siddiqui S; Shamsi A; Alajmi MF; Hussain A; Islam A; Ahmad F; Hassan MI
Molecules; 2020 Feb; 25(4):. PubMed ID: 32070031
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential inhibitors of tropomyosin receptor kinase B targeting CNS-related disorders and cancers.
Hakami MA; Alotaibi BS; Hazazi A; Shafie A; Alsaiari AA; Ashour AA; Anjum F
J Biomol Struct Dyn; 2024 Apr; 42(6):2965-2975. PubMed ID: 37184150
[TBL] [Abstract][Full Text] [Related]
19. Structure-guided identification of potent inhibitors of ROS1 kinase for therapeutic development against non-small cell lung cancer.
Khan MS; Altwaijry N; Al-Bagmi MS; Alafaleq NO; Alokail MS; Shahwan M; Shamsi A
J Biomol Struct Dyn; 2024 May; 42(8):3837-3847. PubMed ID: 37254309
[TBL] [Abstract][Full Text] [Related]
20. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
